We have decided to change the name of our foundation from The Single Cause Single Cure Foundation, to The Foundation for Metabolic Cancer Therapies. We think this name better reflects our ethos. It was pointed out that perhaps Single Cause Single Cure could be interpreted as encouraging patients to seek a single cure. That is not the case. Research has clearly shown that combinations of metabolic acting therapies are synergistic, and have outcomes that far exceed any single agent. We have granted research awarded to investigate synergist “cocktails” of metabolic therapies. The preclinical work is very encouraging. Our goal is to empower patients with these largely non-toxic therapies that may greatly enhance standard of care.